Broad market pushed higher on Tuesday with the Dow Jones industrial average and S&P 500 notching fresh all-time highs. However, the Nasdaq lagged and ARK funds followed suit for the most part. ARKQ performed the best out of the group, with the exchange-traded fund up 0.1%, while ARKG did the worst, down 3%. The gains from last year are slowly sliding away, but Cathie Wood may have something up her sleeve as she is constantly reshuffling her ETFs to stand up to market headwinds.
ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major sells that ARK Invest executed on August 10, 2021. Also check out all the ARK Invest buys that took place today.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here are some notable trades in this fund: Sell 569,300 shares of Base.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. The biggest holdings include the likes of Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable trades in this fund: Sell 121,042 shares of Seer, Sell 116,467 shares of Takeda Pharma, Sell 394,655 shares of Roche, Sell 136,940 shares of Pure Storage, & Sell 53,188 shares of Novartis.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but the focus is primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable trades in this fund: Sell 26,272 shares of 10X Genomics, Sell 66,982 shares of Square, Sell 12,339 shares of Shopify, & Sell 139,500 shares of Nintendo.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused, unsurprisingly, on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. Big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are a few of trades of note in this fund: Sell 35,064 shares of Nvidia.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. Some names in this fund are similar to the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are a couple of notable trades in this fund: Sell 75,109 shares of Netflix.
Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is primarily focused on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. Trades worth noting in this fund: Sell 7,684 shares of Alibaba & Sell 7,578 shares of Nvidia.
Check out all the sells here:
| Fund | Direction | Ticker | Company | Shares |
|---|---|---|---|---|
| ARKF | Sell | 4477JP | BASE INC | 569,300 |
| ARKG | Sell | SEER | SEER INC | 121,042 |
| ARKG | Sell | TAK | TAKEDA PHARMACEUTICAL CO LTD | 116,467 |
| ARKG | Sell | RHHBY | ROCHE HOLDING AG | 394,655 |
| ARKG | Sell | REGN | REGENERON PHARMACEUTICALS INC | 8,271 |
| ARKG | Sell | PSTI | PLURISTEM THERAPEUTICS INC | 7,402 |
| ARKG | Sell | PSTG | PURE STORAGE INC | 136,940 |
| ARKG | Sell | NVS | NOVARTIS AG | 53,188 |
| ARKG | Sell | CLLS | CELLECTIS SA | 600 |
| ARKG | Sell | BMY | BRISTOL-MYERS SQUIBB CO | 72,802 |
| ARKK | Sell | TXG | 10X GENOMICS INC | 26,272 |
| ARKK | Sell | SQ | SQUARE INC | 66,982 |
| ARKK | Sell | SHOP | SHOPIFY INC | 12,339 |
| ARKK | Sell | SE | SEA LTD | 102,270 |
| ARKK | Sell | NTDOY | NINTENDO CO LTD | 139,500 |
| ARKK | Sell | MCRB | SERES THERAPEUTICS INC | 100 |
| ARKK | Sell | DOCU | DOCUSIGN INC | 62,744 |
| ARKQ | Sell | NVDA | NVIDIA CORP | 35,064 |
| ARKW | Sell | NFLX | NETFLIX INC | 75,109 |
| ARKX | Sell | BABA | ALIBABA GROUP HOLDING LTD | 7,684 |
| ARKX | Sell | NVDA | NVIDIA CORP | 7,578 |
Catherine Wood, the CEO and CIO of ARK Investment Management LLC, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
